William Tierney to Cost-Benefit Analysis
This is a "connection" page, showing publications William Tierney has written about Cost-Benefit Analysis.
Connection Strength
0.167
-
The clinical and economic impact of alternative staging strategies for adenocarcinoma of the pancreas. Am J Gastroenterol. 2000 Jul; 95(7):1708-13.
Score: 0.043
-
Demonstrating the effects of an IAIMS on health care quality and cost. J Am Med Inform Assoc. 1997 Mar-Apr; 4(2 Suppl):S41-6.
Score: 0.034
-
Cost-effectiveness of colorectal cancer screening strategies. Gastroenterology. 1996 Jun; 110(6):2026-7.
Score: 0.032
-
ASGE Technology Status Evaluation Report: disposable endoscopic accessories. Gastrointest Endosc. 2005 Oct; 62(4):477-9.
Score: 0.015
-
ASGE Technology Status Evaluation Report: radiographic contrast media used in ERCP. Gastrointest Endosc. 2005 Oct; 62(4):480-4.
Score: 0.015
-
Is upper gastrointestinal radiography a cost-effective alternative to a Helicobacter pylori "test and treat" strategy for patients with suspected peptic ulcer disease? Am J Gastroenterol. 2000 Mar; 95(3):651-8.
Score: 0.010
-
Cost effectiveness of EUS for preoperative localization of pancreatic endocrine tumors. Gastrointest Endosc. 1999 Jan; 49(1):19-25.
Score: 0.010
-
Cost-effectiveness of increased telephone contact for patients with osteoarthritis. A randomized, controlled trial. Arthritis Rheum. 1993 Feb; 36(2):243-6.
Score: 0.006